These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 19845757

  • 1. Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma.
    Bakos RM, Maier T, Besch R, Mestel DS, Ruzicka T, Sturm RA, Berking C.
    Exp Dermatol; 2010 Aug; 19(8):e89-94. PubMed ID: 19845757
    [Abstract] [Full Text] [Related]

  • 2. SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells.
    Flammiger A, Besch R, Cook AL, Maier T, Sturm RA, Berking C.
    J Invest Dermatol; 2009 Apr; 129(4):945-53. PubMed ID: 18923447
    [Abstract] [Full Text] [Related]

  • 3. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
    Shin J, Vincent JG, Cuda JD, Xu H, Kang S, Kim J, Taube JM.
    J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
    [Abstract] [Full Text] [Related]

  • 4. Nestin is expressed in HMB-45 negative melanoma cells in dermal parts of nodular melanoma.
    Kanoh M, Amoh Y, Tanabe K, Maejima H, Takasu H, Katsuoka K.
    J Dermatol; 2010 Jun; 37(6):505-11. PubMed ID: 20536663
    [Abstract] [Full Text] [Related]

  • 5. Nestin expression in cutaneous melanomas and melanocytic nevi.
    Brychtova S, Fiuraskova M, Hlobilková A, Brychta T, Hirnak J.
    J Cutan Pathol; 2007 May; 34(5):370-5. PubMed ID: 17448190
    [Abstract] [Full Text] [Related]

  • 6. Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro.
    Cook AL, Smith AG, Smit DJ, Leonard JH, Sturm RA.
    Exp Cell Res; 2005 Aug 01; 308(1):222-35. PubMed ID: 15896776
    [Abstract] [Full Text] [Related]

  • 7. SOX10 expression in superficial spreading and nodular malignant melanomas.
    Agnarsdóttir M, Sooman L, Bolander A, Strömberg S, Rexhepaj E, Bergqvist M, Ponten F, Gallagher W, Lennartsson J, Ekman S, Uhlen M, Hedstrand H.
    Melanoma Res; 2010 Dec 01; 20(6):468-78. PubMed ID: 20890226
    [Abstract] [Full Text] [Related]

  • 8. Expression of the neuroectodermal intermediate filament nestin in human melanomas.
    Flørenes VA, Holm R, Myklebost O, Lendahl U, Fodstad O.
    Cancer Res; 1994 Jan 15; 54(2):354-6. PubMed ID: 8275467
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of the hair follicle stem cell marker nestin in patients with malignant melanoma.
    Tanabe K, Amoh Y, Kanoh M, Takasu H, Sakai N, Sato Y, Katsuoka K.
    Eur J Dermatol; 2010 Jan 15; 20(3):283-8. PubMed ID: 20156773
    [Abstract] [Full Text] [Related]

  • 10. Nestin is highly expressed in advanced-stage melanomas and neurotized nevi.
    Akiyama M, Matsuda Y, Ishiwata T, Naito Z, Kawana S.
    Oncol Rep; 2013 Apr 15; 29(4):1595-9. PubMed ID: 23417116
    [Abstract] [Full Text] [Related]

  • 11. Tissue microarray analysis of ezrin, KBA.62, CD166, nestin, and p-Akt in melanoma versus banal and atypical nevi, and nonmelanocytic lesions.
    Shanesmith RP, Smart C, Cassarino DS.
    Am J Dermatopathol; 2011 Oct 15; 33(7):663-8. PubMed ID: 21915031
    [Abstract] [Full Text] [Related]

  • 12. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.
    Ramos-Herberth FI, Karamchandani J, Kim J, Dadras SS.
    J Cutan Pathol; 2010 Sep 15; 37(9):944-52. PubMed ID: 20653825
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic utility of neural stem and progenitor cell markers nestin and SOX2 in distinguishing nodal melanocytic nevi from metastatic melanomas.
    Chen PL, Chen WS, Li J, Lind AC, Lu D.
    Mod Pathol; 2013 Jan 15; 26(1):44-53. PubMed ID: 22899289
    [Abstract] [Full Text] [Related]

  • 14. Nestin and vimentin colocalization affects the subcellular location of glucocorticoid receptor in cutaneous melanoma.
    Lai S, Piras F, Spiga S, Perra MT, Minerba L, Piga M, Mura E, Murtas D, Demurtas P, Corrias M, Maxia C, Ferreli C, Sirigu P.
    Histopathology; 2013 Feb 15; 62(3):487-98. PubMed ID: 23072594
    [Abstract] [Full Text] [Related]

  • 15. Sox10: a pan-schwannian and melanocytic marker.
    Nonaka D, Chiriboga L, Rubin BP.
    Am J Surg Pathol; 2008 Sep 15; 32(9):1291-8. PubMed ID: 18636017
    [Abstract] [Full Text] [Related]

  • 16. Interplay of SOX and POU factors in regulation of the Nestin gene in neural primordial cells.
    Tanaka S, Kamachi Y, Tanouchi A, Hamada H, Jing N, Kondoh H.
    Mol Cell Biol; 2004 Oct 15; 24(20):8834-46. PubMed ID: 15456859
    [Abstract] [Full Text] [Related]

  • 17. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
    Brychtova S, Bezdekova M, Brychta T, Tichy M.
    Neoplasma; 2008 Oct 15; 55(4):273-9. PubMed ID: 18505336
    [Abstract] [Full Text] [Related]

  • 18. SOX2 and nestin expression in human melanoma: an immunohistochemical and experimental study.
    Laga AC, Zhan Q, Weishaupt C, Ma J, Frank MH, Murphy GF.
    Exp Dermatol; 2011 Apr 15; 20(4):339-45. PubMed ID: 21410764
    [Abstract] [Full Text] [Related]

  • 19. Nestin expression as a new marker in malignant peripheral nerve sheath tumors.
    Shimada S, Tsuzuki T, Kuroda M, Nagasaka T, Hara K, Takahashi E, Hayakawa S, Ono K, Maeda N, Mori N, Illei PB.
    Pathol Int; 2007 Feb 15; 57(2):60-7. PubMed ID: 17300669
    [Abstract] [Full Text] [Related]

  • 20. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
    Nazarian RM, Prieto VG, Elder DE, Duncan LM.
    J Cutan Pathol; 2010 Apr 15; 37 Suppl 1():41-7. PubMed ID: 20482674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.